X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abridged index medicus (5) 5
index medicus (5) 5
medicine, general & internal (5) 5
aged (4) 4
female (4) 4
humans (4) 4
male (4) 4
middle aged (4) 4
studies (4) 4
cardiovascular diseases (3) 3
care and treatment (3) 3
patients (3) 3
aged, 80 and over (2) 2
amputation (2) 2
anemia (2) 2
aspirin (2) 2
aspirin - adverse effects (2) 2
aspirin - therapeutic use (2) 2
bladder cancer (2) 2
bladder-cancer (2) 2
cancer (2) 2
carcinoma (2) 2
cardiovascular disease (2) 2
cardiovascular diseases - mortality (2) 2
cardiovascular diseases - prevention & control (2) 2
chemotherapy (2) 2
cisplatin (2) 2
clinical activity (2) 2
clinical medicine (2) 2
clinical trials (2) 2
coronary vessels (2) 2
demographics (2) 2
disease control (2) 2
disease prevention (2) 2
double-blind method (2) 2
drug therapy, combination (2) 2
factor xa inhibitors (2) 2
factor xa inhibitors - adverse effects (2) 2
factor xa inhibitors - therapeutic use (2) 2
hemorrhage (2) 2
hemorrhage - chemically induced (2) 2
hospitals (2) 2
incidence (2) 2
journal article (2) 2
life sciences (2) 2
ligands (2) 2
lower extremity (2) 2
medical and health sciences (2) 2
medical research (2) 2
medicin och hälsovetenskap (2) 2
metastasis (2) 2
mortality (2) 2
myocardial infarction (2) 2
pain (2) 2
platelet aggregation inhibitors (2) 2
platelet aggregation inhibitors - adverse effects (2) 2
platelet aggregation inhibitors - therapeutic use (2) 2
risk (2) 2
rivaroxaban (2) 2
rivaroxaban - adverse effects (2) 2
rivaroxaban - therapeutic use (2) 2
therapy (2) 2
tumors (2) 2
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (1) 1
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (1) 1
abdominal wall hernia (1) 1
accidental injury (1) 1
accommodation (1) 1
activities of daily living (1) 1
acute coronary syndromes (1) 1
acute glomerulonephritis (1) 1
acute hepatitis (1) 1
acute hepatitis a (1) 1
adolescent (1) 1
adult (1) 1
adults (1) 1
age (1) 1
aggression (1) 1
aging (1) 1
allmänmedicin (1) 1
alzheimer's disease (1) 1
amputation - adverse effects (1) 1
amputation - rehabilitation (1) 1
amputation - statistics & numerical data (1) 1
amputation, traumatic - complications (1) 1
amputation, traumatic - rehabilitation (1) 1
amputation/statistics & numerical data (1) 1
amputees (1) 1
analysis (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
anticoagulants (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
anxiety (1) 1
apoptosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 67 - 76
Journal Article
The Lancet, ISSN 0140-6736, 02/2018, Volume 391, Issue 10122, pp. 748 - 757
Journal Article
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article